Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center — Los Angeles, California

Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center is a clinical research site located in Los Angeles, California, United States 90048.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center has participated in 35 clinical trials with 1 currently active.

Therapeutic areas: Lung Cancer, Prostate Cancer, Brain Tumor.

Sponsors: Alliance for Clinical Trials in Oncology, Children's Oncology Group, Fred Hutchinson Cancer Center.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center?

Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center conducted?

Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center has 35 clinical trials on record, with 1 currently active. Their work covers Lung Cancer, Prostate Cancer, Brain Tumor.

Is Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center accredited by Crixeo Health?

Yes — Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.